Celgene Alpine Investment Co., LLC, 10% Owner at AGIOS PHARMACEUTICALS, INC. (AGIO), bought 403,225 shares at $31.00 ($12.5M) on 2019-11-12, disclosed to the SEC on 2019-11-14.
Open-market purchase of $12.5M AGIO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.